发明名称 |
Stem cell immune modulation methods of use and apparatus |
摘要 |
Methods and apparatus are disclosed co-culturing stem cells with mononuclear cells and/or lymphocytes to modulate their function. The invention also discloses the use of stem cells to educate autoreactive immune cells as a mechanism to treat autoimmune diseases and immune disorder-related diseases, such as diabetes. In one aspect of the invention, bioreactors are disclosed closed for modulating lymphocytes and suppressing autoreactive T cells. The bioreactors can include a chamber having at least one positively charged and/or hydrophobic substrate surface, a population of stem cells attached to the substrate surface, an inlet conduit for introducing lymphocytes into the chamber, and an outlet conduit for extracting treated lymphocytes following co-culturing with the stem cells. |
申请公布号 |
US9101726(B2) |
申请公布日期 |
2015.08.11 |
申请号 |
US201013514694 |
申请日期 |
2010.12.08 |
申请人 |
The Board of Trustees of the University of Illinois |
发明人 |
Zhao Yong |
分类号 |
A61M37/00;A61M1/34;C12N5/078;C12M1/12;C12M1/42;A61K35/12 |
主分类号 |
A61M37/00 |
代理机构 |
Greenberg Traurig, LLP |
代理人 |
Rao Weisun;Greenberg Traurig, LLP |
主权项 |
1. A bioreactor for modulating lymphocytes and suppressing autoreactive T cells, comprising:
a chamber having at least one positively charged and hydrophobic substrate surface; a population of stem cells attached to the substrate surface, wherein the stem cells are characterized by: (a) displaying embryonic stem cell characteristics; (b) displaying hematopoietic cell characteristics as being positive for leukocyte common antigen CD45; (c) not expressing the CD34 marker; (d) displaying low immunogenicity; and (e) expressing autoimmune regulator; an inlet conduit for introducing lymphocytes into the chamber for co-culturing with the stem cells, and the lymphocytes are free from plasma before being introduced into the chamber; and an outlet conduit for extracting the lymphocytes following co-culturing with the stem cells. |
地址 |
Urbana IL US |